| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income, net | 317,560 | 357,871 | 408,850 | 642,732 |
| Net loss | -7,726,639 | -6,258,404 | -4,894,034 | -4,753,541 |
| Net unrealized gain (loss) on marketable securities | 6,607 | -22,006 | -34,974 | 142,864 |
| Total comprehensive loss | -7,720,032 | -6,280,410 | -4,929,008 | -4,610,677 |
| Diluted eps | - | - | - | -0.55 |
| Diluted average shares | - | - | - | 8,702,764 |
| Net loss per share of common stock, basic and diluted (in dollars per share) | -0.84 | -0.7 | -0.56 | -0.55 |
| Weighted average shares outstanding, basic and diluted (in shares) | 9,252,719 | 8,950,521 | 8,702,719 | 8,702,764 |
CervoMed Inc. (CRVO)
CervoMed Inc. (CRVO)